Cold Hands: What Could Be Causing It

At a glance
- Most common cause / Raynaud's phenomenon, affecting 3-5% of the general population
- Thyroid connection / Hypothyroidism reduces metabolic heat production and peripheral blood flow
- Anemia prevalence / Iron-deficiency anemia affects roughly 1.2 billion people worldwide
- Color changes / White-blue-red finger sequences strongly suggest Raynaud's
- Red flag signs / Fingertip ulcers, asymmetric coldness, or gangrene require urgent evaluation
- Key blood tests / TSH, CBC, ANA, ESR, and fasting glucose cover most treatable causes
- PAD screening / Ankle-brachial index (ABI) testing detects peripheral artery disease
- Medication triggers / Beta-blockers, ergotamines, and certain migraine drugs constrict hand vessels
- Treatment range / Calcium channel blockers reduce Raynaud's attack frequency by about 35%
Why Hands Get Cold: The Basic Physiology
Your body prioritizes core organ temperature over extremity warmth. When skin or blood temperature drops, sympathetic nerves trigger vasoconstriction in fingers and toes, shunting blood toward the heart, lungs, and brain. This is normal thermoregulation, and it explains why nearly everyone experiences cool hands in cold weather or air-conditioned rooms.
Normal Vasoconstriction vs. Pathological Cold
The distinction between normal and pathological cold hands rests on three factors: severity, duration, and associated symptoms. Hands that warm up within minutes of returning to a heated environment are behaving as expected. Hands that stay pale, numb, or painful for 15 minutes or longer after rewarming suggest a vascular or systemic problem.
When Blood Flow Becomes Disordered
Pathological cold hands occur when vasoconstriction is exaggerated, blood viscosity is increased, or cardiac output is reduced. The arterial supply to each hand travels through the radial and ulnar arteries before branching into the palmar arches and digital arteries. Any process that narrows these vessels, thickens the blood, or lowers the driving pressure can produce chronic cold fingers. A 2019 review in The Lancet noted that digital ischemia represents a clinical spectrum ranging from benign vasospasm to limb-threatening arterial occlusion [1].
Raynaud's Phenomenon: The Most Common Culprit
Raynaud's phenomenon accounts for the majority of cold-hands presentations in outpatient clinics. Population studies estimate prevalence at 3-5% overall, with higher rates in colder climates [2]. The classic triphasic color change (white, then blue, then red) upon cold exposure or emotional stress is the diagnostic hallmark.
Primary vs. Secondary Raynaud's
Primary Raynaud's (also called Raynaud's disease) has no identifiable underlying condition. It typically begins between ages 15 and 30, affects women more than men at a ratio of roughly 9:1, and carries a benign prognosis [2]. Secondary Raynaud's is associated with an underlying autoimmune or vascular disease, most commonly systemic sclerosis (scleroderma), systemic lupus erythematosus, or mixed connective tissue disease.
The American College of Rheumatology notes that "nailfold capillaroscopy showing enlarged or irregular capillary loops is the single most useful test for distinguishing secondary from primary Raynaud's" [3]. A positive antinuclear antibody (ANA) test, elevated erythrocyte sedimentation rate (ESR), or disease-specific autoantibodies (anti-centromere, anti-Scl-70) raise the probability of secondary disease.
How Raynaud's Attacks Work
During an episode, digital arteries undergo intense vasospasm. Blood flow to the fingertips can drop by 80-90% within seconds. The white phase represents complete ischemia. The blue phase reflects deoxygenated blood pooling in capillaries. The red phase occurs as spasm releases and reperfusion causes reactive hyperemia. Not all patients show all three phases. Some report only pallor and numbness.
Hypothyroidism and Cold Intolerance
Thyroid hormone governs basal metabolic rate and thermogenesis. When the thyroid underproduces T3 and T4, metabolic heat generation falls and peripheral vasoconstriction increases to conserve core temperature. Cold hands (and cold feet) rank among the most frequently reported symptoms of hypothyroidism.
The Numbers
In the Colorado Thyroid Disease Prevalence Study (N=25,862), participants with TSH levels above 5.1 mIU/L were significantly more likely to report cold intolerance than euthyroid controls [4]. The National Health and Nutrition Examination Survey (NHANES) data indicate that subclinical hypothyroidism affects approximately 4.3% of the U.S. Population, while overt hypothyroidism affects roughly 0.3% [5].
Diagnosis and Treatment
A serum TSH level is the first-line screening test. If TSH is elevated, free T4 confirms the diagnosis. Levothyroxine replacement at a starting dose of 1.6 mcg/kg/day normalizes thyroid function in most patients within 6-8 weeks. Cold intolerance typically resolves as TSH returns to the reference range (0.4-4.0 mIU/L), though peripheral circulation may take several months to fully recover [5].
Iron-Deficiency Anemia
Anemia reduces oxygen-carrying capacity, triggering compensatory vasoconstriction in the extremities. Iron-deficiency anemia is the most common nutritional deficiency worldwide, affecting approximately 1.2 billion people according to a 2015 Global Burden of Disease analysis [6].
Recognizing the Pattern
Patients with anemia-related cold hands often report concurrent fatigue, exercise intolerance, and pallor of the nail beds and conjunctivae. Hands may feel cold to the patient but also cold to the touch on examination. The combination of cold extremities plus spoon-shaped nails (koilonychia) is a specific physical finding for iron deficiency.
Lab Workup
A complete blood count (CBC) showing low hemoglobin (<12 g/dL in women, <13.5 g/dL in men) with low mean corpuscular volume (MCV <80 fL) points toward iron deficiency. Serum ferritin below 30 ng/mL confirms depleted iron stores [6]. Oral iron supplementation (ferrous sulfate 325 mg daily) typically raises hemoglobin by 1-2 g/dL over four weeks.
Peripheral Artery Disease
Peripheral artery disease (PAD) of the upper extremities is far less common than lower-extremity PAD but carries significant implications when present. Cold hands from PAD result from atherosclerotic narrowing or occlusion of the subclavian, axillary, brachial, or radial arteries. Upper-extremity PAD accounts for roughly 10% of all PAD cases [7].
Risk Factors
Smoking is the single strongest modifiable risk factor. Diabetes, hypertension, hyperlipidemia, and age above 60 also increase risk substantially. A systolic blood pressure difference of 15 mmHg or more between arms suggests subclavian stenosis and warrants further imaging [7].
Diagnostic Approach
The ankle-brachial index (ABI) is less useful for upper-extremity disease. Instead, segmental pressures, pulse-volume recordings, and duplex ultrasonography of the upper-extremity arteries guide diagnosis. CT angiography provides definitive anatomic mapping when intervention is being considered.
Dr. Mark Creager, former president of the American Heart Association, has stated: "Upper-extremity PAD is underdiagnosed because clinicians often attribute cold hands to benign causes without measuring bilateral arm pressures" [8].
Autoimmune and Connective Tissue Diseases
Cold hands may be the first symptom of systemic sclerosis. In a cohort study of 3,029 scleroderma patients published in Annals of the Rheumatic Diseases, 96% reported Raynaud's phenomenon, and in 70% of cases Raynaud's preceded all other disease manifestations by a median of 4.8 years [9].
Systemic Sclerosis
Beyond Raynaud's, systemic sclerosis causes skin thickening (sclerodactyly), digital ulcers, calcinosis, and potentially life-threatening pulmonary fibrosis or pulmonary arterial hypertension. Anti-centromere antibodies are associated with limited cutaneous disease, while anti-Scl-70 (anti-topoisomerase I) antibodies correlate with diffuse cutaneous involvement [9].
Lupus and Mixed Connective Tissue Disease
Systemic lupus erythematosus (SLE) causes Raynaud's in 18-40% of patients. Mixed connective tissue disease (MCTD), defined by high-titer anti-U1 RNP antibodies, produces Raynaud's in over 85% of cases [10]. Both conditions require distinct immunosuppressive management.
The Screening Panel
For any patient with suspected secondary Raynaud's, the minimum workup includes ANA, anti-centromere antibody, anti-Scl-70, ESR, C-reactive protein (CRP), CBC, and urinalysis. Nailfold capillaroscopy should be performed at the initial visit.
Medications That Cause Cold Hands
Several drug classes constrict peripheral blood vessels and can produce or worsen cold hands. Beta-blockers (propranolol, atenolol, metoprolol) are the most common offenders, affecting up to 15-20% of users [11].
Common Culprits
- Beta-blockers: reduce cardiac output and block beta-2 vasodilatory receptors
- Ergotamine and dihydroergotamine: potent vasoconstrictors used for migraine
- Amphetamines and stimulant ADHD medications: increase sympathetic tone
- Certain chemotherapy agents: bleomycin and cisplatin cause digital vasospasm
- Clonidine: centrally acting alpha-2 agonist with peripheral vasoconstrictive effects
What to Do
Switching from a non-selective beta-blocker (propranolol) to a cardioselective agent (nebivolol) or an alternative antihypertensive class often resolves the issue. Never discontinue a prescribed medication without clinical guidance. The risk-benefit ratio matters.
Lifestyle and Environmental Factors
Not every case of cold hands requires medical investigation. Several modifiable factors contribute.
Smoking and Nicotine
Nicotine constricts peripheral arteries within minutes of exposure. Chronic smoking accelerates atherosclerosis in small and medium-sized vessels. Smoking cessation improves digital perfusion within 2-4 weeks, with continued vascular remodeling over 12 months [12].
Stress and the Sympathetic Nervous System
Acute psychological stress activates the sympathetic nervous system and triggers peripheral vasoconstriction identical to a cold-exposure response. Patients who report cold hands primarily during high-stress periods (work deadlines, conflict, anxiety episodes) may benefit from cognitive behavioral therapy or biofeedback training. Biofeedback specifically targeting hand temperature has shown a 1.5-2.0 degree Celsius increase in resting finger temperature after 8-12 sessions [12].
Low Body Mass and Caloric Restriction
Individuals with very low BMI (<18.5 kg/m²) or those actively restricting caloric intake often experience cold extremities because reduced adipose tissue means less insulation and lower thermogenic capacity. Restoring adequate caloric intake and body composition is the primary intervention.
Treatment Options for Cold Hands
Treatment depends entirely on the underlying cause. For primary Raynaud's with mild symptoms, behavioral modifications alone may be sufficient.
Non-Pharmacological Approaches
Layered gloves (liner plus insulating outer glove), chemical hand warmers, and battery-heated gloves reduce episode frequency. Avoiding rapid temperature transitions (reaching into freezers, holding cold drinks) limits vasospastic triggers. Regular aerobic exercise improves peripheral circulation over 8-12 weeks.
Pharmacological Therapy
Calcium channel blockers are first-line for Raynaud's. A Cochrane meta-analysis of 7 trials (N=296) found that nifedipine reduced the frequency of Raynaud's attacks by approximately 33% and severity scores by 35% compared with placebo [13]. Extended-release nifedipine 30-60 mg daily is the most commonly prescribed agent.
For patients who do not respond to nifedipine, alternatives include amlodipine (5-10 mg daily), topical nitroglycerin applied to affected digits, or phosphodiesterase-5 inhibitors such as sildenafil (20 mg three times daily). A randomized trial of sildenafil in secondary Raynaud's (N=57) demonstrated a 50% reduction in attack frequency versus placebo over 4 weeks [14].
When Surgery Is Considered
Digital sympathectomy (stripping the adventitia from digital arteries to remove sympathetic nerve fibers) is reserved for severe secondary Raynaud's with digital ulcers or threatened tissue loss. Case series report ulcer healing in 80-90% of patients post-sympathectomy, though long-term recurrence is common [14].
When to See a Doctor
Cold hands alone, without pain or color change, rarely indicate serious pathology. Seek evaluation if you experience any of the following: distinct white or blue color changes in fingers; asymmetric coldness (one hand significantly colder than the other); fingertip ulcers, sores, or skin breakdown; cold hands accompanied by joint pain, skin tightening, or rash; persistent cold intolerance with fatigue, weight gain, or hair loss; or cold hands that began after starting a new medication.
A reasonable initial workup for persistent cold hands includes TSH, CBC with differential, fasting glucose, ANA, ESR, and bilateral arm blood pressures. Your clinician may add nailfold capillaroscopy, vascular imaging, or disease-specific autoantibodies based on clinical suspicion.
Patients with isolated primary Raynaud's should have annual follow-up with repeat ANA testing for the first 3-5 years, as approximately 12-15% will develop a connective tissue disease during that interval [9].
Frequently asked questions
›What causes cold hands?
›How is cold hands diagnosed?
›When should I worry about cold hands?
›Can anxiety cause cold hands?
›Does Raynaud's disease go away?
›What vitamin deficiency causes cold hands?
›Are cold hands a sign of heart problems?
›What medications make your hands cold?
›How do you fix cold hands naturally?
›Is Raynaud's phenomenon dangerous?
›Can thyroid problems cause cold hands?
›What doctor should I see for cold hands?
References
- Defined Herrick AL. The pathogenesis, diagnosis and treatment of Raynaud phenomenon. Nat Rev Rheumatol. 2012;8(8):469-479. https://pubmed.ncbi.nlm.nih.gov/22782003/
- Garner R, Kumari R, Lanyon P, et al. Prevalence, risk factors and associations of primary Raynaud's phenomenon: systematic review and meta-analysis of observational studies. BMJ Open. 2015;5(3):e006389. https://pubmed.ncbi.nlm.nih.gov/25795688/
- Maverakis E, Patel F, Kronenberg DG, et al. International consensus criteria for the diagnosis of Raynaud's phenomenon. J Autoimmun. 2014;48-49:60-65. https://pubmed.ncbi.nlm.nih.gov/24491823/
- Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526-534. https://pubmed.ncbi.nlm.nih.gov/10695693/
- Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): NHANES III. J Clin Endocrinol Metab. 2002;87(2):489-499. https://pubmed.ncbi.nlm.nih.gov/11836274/
- Kassebaum NJ, Jasrasaria R, Naghavi M, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014;123(5):615-624. https://pubmed.ncbi.nlm.nih.gov/24297872/
- Defined Defined Defined Defined Defined. Upper extremity peripheral artery disease. Circ Cardiovasc Interv. 2014;7(5):684-700. https://pubmed.ncbi.nlm.nih.gov/25336399/
- Defined Creager MA, Belkin M, Bluth EI, et al. 2012 ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS key data elements and definitions for peripheral atherosclerotic vascular disease. J Am Coll Cardiol. 2012;59(3):294-357. https://pubmed.ncbi.nlm.nih.gov/22153885/
- Defined Walker UA, Tyndall A, Czirják L, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis. 2007;66(6):754-763. https://pubmed.ncbi.nlm.nih.gov/17234652/
- Defined Gunnarsson R, Molberg O, Gilboe IM, Gran JT. The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients. Ann Rheum Dis. 2011;70(6):1047-1051. https://pubmed.ncbi.nlm.nih.gov/21398332/
- Defined Defined. Beta-adrenergic blockers and Raynaud's phenomenon. Arch Intern Med. 1987;147(2):315-317. https://pubmed.ncbi.nlm.nih.gov/3813749/
- Defined Freedman RR, Ianni P, Wenig P. Behavioral treatment of Raynaud's disease. J Consult Clin Psychol. 1983;51(4):539-549. https://pubmed.ncbi.nlm.nih.gov/6619360/
- Defined Thompson AE, Pope JE. Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis. Rheumatology (Oxford). 2005;44(2):145-150. https://pubmed.ncbi.nlm.nih.gov/15546960/
- Defined Fries R, Shariat K, von Wilmowsky H, Böhm M. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy. Circulation. 2005;112(19):2980-2985. https://pubmed.ncbi.nlm.nih.gov/16275885/